New drug HU6 targets fatty liver disease in Mid-Stage trial

NCT ID NCT07491458

Recruiting now Disease control Sponsor: Rivus Pharmaceuticals, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called HU6 for people with MASH, a serious fatty liver disease. About 180 adults aged 30 and older will receive either HU6 or a placebo to see if the drug safely reduces liver fat. The trial lasts 26 weeks and focuses on safety and how well the drug works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metabolic dysfunction-associated steatohepatitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MASH - METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS

Contacts and locations

Locations

Arizona Liver Health - Chandler
RECRUITING

Chandler, Arizona, 85224, United States
Arizona Liver Health - Peoria
RECRUITING

Peoria, Arizona, 85381, United States
Arizona Liver Health - Tucson
RECRUITING

Tucson, Arizona, 85712, United States
Baptist Health Center for Clinical Research
RECRUITING

Little Rock, Arkansas, 72205, United States
Bellaire Clinical Research, LLC
RECRUITING

Bellaire, Texas, 77401, United States
Catalina Research Institute
RECRUITING

Montclair, California, 91763, United States
Charter Research LLC - Chicago
RECRUITING

Chicago, Illinois, 60618, United States
Charter Research LLC - Orlando
RECRUITING

Orlando, Florida, 32803, United States
Clinical Research Institute of Michigan
RECRUITING

Clinton Township, Michigan, 48038, United States
Clinical Research Institute of Ohio, LLC (CRIOH)
RECRUITING

Westlake, Ohio, 44145, United States
Coastal Research Institute
RECRUITING

Fayetteville, North Carolina, 28304, United States
Delta Research Partners of Bastrop, LLC
RECRUITING

Bastrop, Louisiana, 71220, United States
Delta Research Partners of West Monroe, LLC
RECRUITING

West Monroe, Louisiana, 71291, United States
HRI - Medical Center, LLC
RECRUITING

Houston, Texas, 77030, United States
HRI - Pasadena, LLC
RECRUITING

Pasadena, Texas, 77505, United States
HRI - Sugarland, LLC
RECRUITING

Sugar Land, Texas, 77478, United States
Houston Research Institute
RECRUITING

Houston, Texas, 77079, United States
IMA Clinical Research (Austin)
RECRUITING

Austin, Texas, 78745, United States
Innovative Clinical Research, LLC
RECRUITING

Clarksville, Tennessee, 37040, United States
Jubilee Clinical Research, LLC.
RECRUITING

Las Vegas, Nevada, 89106, United States
KAD Clinical Research
RECRUITING

St Louis, Missouri, 63123, United States
Kansas City Research Institute
RECRUITING

Kansas City, Missouri, 64131, United States
Knowledge Research Center
RECRUITING

Orange, California, 92868, United States
National Institute of Clinical Research
RECRUITING

Garden Grove, California, 92844, United States
Nucleus Network Minneapolis
RECRUITING

Saint Paul, Minnesota, 55114, United States
Pinnacle Clinical Research - Austin
RECRUITING

Austin, Texas, 78757, United States
Pinnacle Clinical Research - Corpus Christi
RECRUITING

Corpus Christi, Texas, 78404, United States
Pinnacle Clinical Research - Georgetown
RECRUITING

Georgetown, Texas, 78626, United States
Pinnacle Clinical Research - San Antonio
RECRUITING

San Antonio, Texas, 78229, United States
Quality Research
RECRUITING

San Antonio, Texas, 78209, United States
Tekton Research - Yukon
RECRUITING

Yukon, Oklahoma, 73099, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.